Effects of catechol-O-methyltransferase (COMT) inhibition on the pharmacokinetics of L-DOPA
Nutt, J.G.
Advances in Neurology 69: 493-496
1996
ISSN/ISBN: 0091-3952 PMID: 8615170 Document Number: 460325
Document emailed within 1 workday
Related Documents
Inoue, K.; Creveling, C.R. 1995: Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone: inhibition by RU-486 Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(3): 430-432Laury, M.C.; Bertin, R.; Portet, R.; Chevillard, L. 1971: Action of catechol-O-methyltransferase on norepinephrine effects in rats adaptated to various temperatures Journal de Physiologie 63(3): 318-321
Davidson, J.R.; McLeod, M.N.; Turnbull, C.D.; White, H.L.; Feuer, E.J. 1979: Catechol-O-methyltransferase activity and classification of depression Biological Psychiatry 14(6): 937-942
Rapin, J.R.; Caillard, R.C.; Cohen, Y.; Valette, G. 1971: Action of catechol O methyltransferase inhibitors on the distribution of norepinephrine-H 3 in rats Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(1): 60-64
Napolitano, A.; Cesura, A.M.; Da Prada, M. 1995: The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission Journal of Neural Transmission. Supplementum 45: 35-45
Creveling, C.R.; Morris, N.; Shimizu, H.; Ong, H.H.; Daly, J. 1972: Catechol O-methyltransferase. IV. Factors affecting m- and p-methylation of substituted catechols Molecular Pharmacology 8(4): 398-409
Morikawa, J.; Yoshida, S.; Kennedy, S.; Takemura, N.; Sugimoto, M.; Kitao, K.; Deguchi, M.; Ohara, N.; Maruo, T. 2008: Association study between catechol-O-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population Clinical and Experimental Obstetrics and Gynecology 35(1): 35-40
Krivonos, O.V.; Fedorova, N.V.; Chigir', I.P. 2004: A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(1): 24-30
Allen, E.; Pettigrew, A.; Frank, D.; Thompson, S.; Myers, C.; Yamashita, T.; Blumer, J.L. 1997: Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children Critical Care Medicine 25(1): 181-189
Blair, M.L.; Reid, I.A.; Ganong, W.F. 1977: Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs Journal of Pharmacology and Experimental Therapeutics 202(1): 209-215
Pontiroli, A.E.; Castegnaro, E.; Vettaro, M.P.; Viberti, G.C.; Pozza, G. 1977: Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine Acta Endocrinologica 84(1): 36-44
Poewe, W. 2004: The role of COMT inhibition in the treatment of Parkinson's disease Neurology 62(1 Suppl 1): S31-S38
1999: Peripheral COMT-inhibition with Entacapon. Optimal therapy of Parkinson disease Der Nervenarzt 70(6 Suppl): 1-8
Baron, M.; Levitt, M.; Asnis, L.; Fein, M. 1983: Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity Biological Psychiatry 18(5): 579-582
Muenter, M.D.; Tyce, G.M. 1971: L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects Mayo Clinic Proceedings 46(4): 231-239
Geissbuhler, F.; Eisenring, J.J.; Friedli, P.; Bartholini, G.; Tissot, R. 1972: Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects L'Encephale 61(2): 127-148
Nishimura, M.; Umeda, M.; Kusanagi, A.; Urakabe, R.; Yukimatsu, K.; Otawara, S. 1981: Cytomorphological study of cultured mammalian cells treated with benzaldehyde, catechol and their derivatives with special reference to inhibition of DNA synthesis Gan 72(2): 272-279
Woodson, L.C.; Ames, M.M.; Selassie, C.D.; Hansch, C.; Weinshilboum, R.M. 1983: Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives Molecular Pharmacology 24(3): 471-478
Hirosawa, I.; Asaeda, G.; Arizono, H.; Shimbo, S.; Ikeda, M. 1976: Effects of catechol on human subjects: a field survey International Archives of Occupational and Environmental Health 37(2): 107-114
Vamvakidès, A. 1993: Action mechanism of L-dopa: dopaminergic activation or glutamatergic inhibition? Annales Pharmaceutiques Francaises 51(1): 8-15